C16-Ceramide

C16-Ceramide is an activator of p53 used in studies of Apoptosis and Protein Degradation / Proteasome. It is especially relevant in apoptosis, cancer, and cell cycle models, where defined compound exposure can be linked to caspase-associated cell-death signaling and survival decisions and ubiquitin-dependent turnover, proteostasis, and targeted protein degradation.

By activating p53, C16-Ceramide can be used to examine caspase-associated cell-death signaling and survival decisions and ubiquitin-dependent turnover, proteostasis, and targeted protein degradation. This context is compatible with apoptosis, viability, and caspase-readout assays and degradation, proteasome, and protein-turnover assays, as well as transcriptional, biochemical, or phenotypic comparisons linked to the annotated pathway state. In apoptosis, cancer, and cell cycle models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving p53
• Pathway perturbation studies connected to Apoptosis and Protein Degradation / Proteasome
• Gain-of-function pathway-activation studies
• Phenotypic profiling in apoptosis, cancer, and cell cycle models

Overall, C16-Ceramide is appropriate when a defined chemical perturbant is needed to connect p53 with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in apoptosis, cancer, and cell cycle models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.